USPTO Examiner BOUCHELLE LAURA A - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19028654DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025April 2025Allow310NoNo
18981958All-In-One Delivery Sheath/Catheter - NOORCATHDecember 2024May 2025Allow510YesNo
18862350FEMORAL ARTERY CANNULA FOR PROVIDING LOWER LIMB BLOOD PERFUSIONNovember 2024February 2025Allow400NoNo
18842993Test Fish Holding Device and Test Fish Treatment MethodAugust 2024May 2025Allow801NoNo
18778749TOTAL JOINT REPLACEMENT INFECTION CONTROL DEVICES AND METHODSJuly 2024November 2024Allow400NoNo
18668929INFUSION PUMP SYSTEMS WITH DISPOSABLE CARTRIDGE HAVING PRESSURE VENTING AND PRESSURE FEEDBACKMay 2024May 2025Allow1210NoNo
18655121Systems and Methods for Monitoring Operations of an Infusion Delivery Device Using a Pressure SensorMay 2024July 2024Allow200NoNo
18630157PATCH PUMP CARTRIDGE ATTACHMENTApril 2024March 2025Allow1110NoNo
18619996HOLD DETENT MECHANISM FOR INJECTION DEVICESMarch 2024August 2024Allow510NoNo
18620097COLLAR HOLD DETENT MECHANISM AND LOCK FOR INJECTION DEVICESMarch 2024September 2024Allow510NoNo
18602886RAPID FLUID DELIVERY SYSTEMMarch 2024June 2025Abandon1510NoNo
18594556MEDICAMENT DELIVERY DEVICEMarch 2024August 2024Allow510YesNo
18436151PATIENT INTERFACEFebruary 2024April 2024Allow200NoNo
18406991FLUSHING APPARATUS FOR USE WITH AN IV INFUSION SET AND AN IV INFUSION SET HAVING AN AUTOMATIC FLUSHING FUNCTIONJanuary 2024September 2024Allow921NoNo
18407295INFUSION PUMP SYSTEMS AND METHODSJanuary 2024January 2025Allow1210NoNo
18401097SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATIONDecember 2023April 2025Allow1610NoNo
18494419CUSHION/FRAME SUB-ASSEMBLY CONNECTABLE TO OUTER FRAMEOctober 2023April 2024Allow620NoNo
18285476MEDICAL PENETRATION DEVICE AND SYSTEMOctober 2023March 2025Allow1720YesNo
18478899REMOVABLE WEARABLE DEVICE AND RELATED ATTACHMENT METHODSSeptember 2023March 2025Allow1821NoNo
18278538INTRACANALICULAR DEPOT INSERTER DEVICEAugust 2023January 2024Allow500NoNo
18449421SYSTEMS AND METHODS FOR PROVIDING A STEERABLE SHEATH WITH IMPROVED TORQUE TRANSFER DURING DEFLECTIONAugust 2023May 2024Allow900NoNo
18447903WEARABLE DRUG DELIVERY DEVICEAugust 2023May 2025Allow2121NoNo
18275878SYSTEMS AND METHODS FOR PRIMING A FLUID LINEAugust 2023September 2024Allow1420NoNo
18229970Plungerless Aspiration And/Or Injection Device And Method Using The SameAugust 2023February 2024Allow710YesNo
18359301DEVICES, SYSTEMS AND METHODS FOR DETACHMENT OF RELEASABLE DEVICESJuly 2023December 2023Allow400NoNo
18333150Another Insert Piece For A Blood Tubing Set To Promote Mixing An Infusion Solution With A Further FluidJune 2023October 2024Allow1610NoNo
18206436ADVANCED DIALYSIS CATHETER WITH PRESSURE SENSORJune 2023June 2025Abandon2410NoNo
18144480DECONSTRUCTABLE ENDOLUMINAL DEVICES AND RELATED SYSTEMS AND METHODSMay 2023February 2025Allow2121NoNo
18312527METHODS AND SYSTEMS FOR DELIVERING GAS TO A PATIENTMay 2023February 2025Allow2210NoNo
18134984PINCH CLAMPApril 2023September 2024Allow1710NoNo
18030271LIQUID MEDICINE INJECTION DEVICEApril 2023January 2024Allow1010NoNo
18128559THERAPEUTIC AGENTS FOR DELIVERY USING A CATHETER AND PRESSURE SOURCEMarch 2023January 2025Allow2210NoNo
18127050Priming Valve to Induce Appropriate Pressure and Flow Profile and Improve Sensor ReadinessMarch 2023January 2025Allow2210NoNo
18189847DEVICES AND METHODS FOR INCREASING BLOOD PERFUSION TO A DISTAL EXTREMITYMarch 2023April 2024Allow1311NoNo
18124025CUSHION/FRAME ASSEMBLY FOR A PATIENT INTERFACEMarch 2023October 2023Allow710NoNo
18180825STEERABLE INTRODUCER SHEATH ASSEMBLYMarch 2023September 2024Allow1920NoNo
18118066PATCH PUMP SYSTEMS AND APPARATUS FOR MANAGING DIABETES, AND METHODS THEREOFMarch 2023August 2024Allow1710NoNo
18116436ERGONOMIC STEERING HANDLEMarch 2023January 2025Allow2310NoNo
18173959SYSTEMS, APPARATUS, AND METHODS FOR FILTERING AIR FROM A FLUID LINEFebruary 2023June 2025Allow2811NoNo
18171339FLUID DELIVERY AND INFUSION DEVICES, AND METHODS OF USE THEREOFFebruary 2023August 2024Allow1810NoNo
18101455Adjustable Stepped CannulaJanuary 2023May 2025Allow2820NoNo
18154211STEERABLE FLEXIBLE NEEDLE WITH EMBEDDED SHAPE SENSINGJanuary 2023January 2025Allow2410NoNo
18095348MEDICAMENT DELIVERY DEVICEJanuary 2023April 2024Allow1510NoNo
18094778MEDICAMENT DELIVERY DEVICEJanuary 2023July 2023Allow610NoNo
18093946SYSTEM AND METHOD FOR SYRINGE PLUNGER ENGAGEMENT WITH AN INJECTORJanuary 2023May 2024Allow1710NoNo
18083707PATIENT INTERFACEDecember 2022November 2023Allow1120YesNo
18082732Wearable Injector with Adhesive ModuleDecember 2022March 2025Abandon2720NoNo
18082074MEDICINE ADMINISTERING SYSTEM INCLUDING INJECTION PEN AND COMPANION DEVICEDecember 2022March 2025Allow2711NoNo
17993309INTRAOCULAR DELIVERY DEVICES AND METHODS THEREFORNovember 2022October 2023Allow1120YesNo
18058088CANNULAS FOR SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATIONNovember 2022July 2023Allow820YesNo
18058003SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATIONNovember 2022June 2023Allow610NoNo
17987578In Vivo Gene Therapy Delivery Procedure and DeviceNovember 2022February 2025Allow2720NoNo
17983717CUSHION TO FRAME ASSEMBLY MECHANISMNovember 2022February 2023Allow310NoNo
17971080TOTAL JOINT REPLACEMENT INFECTION CONTROL DEVICES AND METHODSOctober 2022April 2025Allow3010NoNo
17959194RAPID FLUID DELIVERY SYSTEMOctober 2022December 2023Allow1430NoNo
17952445MEDICAL DEVICES HAVING RELEASABLE COUPLINGSeptember 2022August 2024Allow2320NoNo
17948088Injection Site Targeting DeviceSeptember 2022March 2025Allow3001NoNo
17931465BIORESORBABLE EMBOLIZATION MICROSPHERESSeptember 2022October 2024Abandon2510NoNo
17940233CATHETER AND CATHETER ASSEMBLYSeptember 2022July 2024Allow2210NoNo
17900262ROTATABLE INFUSION DEVICE AND METHODS THEREOFAugust 2022February 2024Allow1800NoNo
17897982APPARATUS, SYSTEMS AND METHODS FOR AN INFUSION PUMP ASSEMBLYAugust 2022April 2024Allow1910NoNo
17891990ANTIMICROBIAL DEVICE COMPRISING A CAP WITH RING AND INSERTAugust 2022June 2024Allow2210YesNo
17881170Ultrasonic Surgical Aspiration Needle Assembly with Molded HubAugust 2022June 2025Allow3400NoNo
17846437Applicator For Cryoanesthesia And AnalgesiaJune 2022May 2024Allow2310NoNo
17833202CUSHION TO FRAME ASSEMBLY MECHANISMJune 2022September 2022Allow310NoNo
17752438DRUG DISPENSING SYSTEM WITH REPLACEABLE DRUG SUPPLY CARTRIDGESMay 2022March 2024Allow2210YesNo
17744362INJECTION APPARATUSMay 2022February 2024Allow2210NoNo
17662567INJECTION SYRINGEMay 2022July 2024Abandon2610NoNo
17731588DEVICES AND METHODS FOR INCREASING BLOOD PERFUSION TO A DISTAL EXTREMITYApril 2022November 2022Allow710NoNo
17727104MINIATURIZED PATCH PUMP SYSTEMApril 2022June 2025Allow3810NoNo
17657314ELECTRICALLY ENHANCED RETRIEVAL OF MATERIAL FROM VESSEL LUMENSMarch 2022August 2024Allow2920YesNo
17764563CASSETTE ASSEMBLY FOR AMBULATORY DRUG PUMPMarch 2022September 2022Allow600NoNo
17706657CASSETTE ASSEMBLY FOR AMBULATORY DRUG PUMPMarch 2022July 2024Allow2710NoNo
17702502CATHETER AND SYSTEMS FOR PROVIDING RADIAL ARTERY ACCESS OF AT LEAST ONE OF A CONTRALATERAL SUBCLAVIAN ARTERY AND AN INTERNAL MAMMARY ARTERY OF A PATIENT FOR DIAGNOSTIC AND INTERVENTIONAL ANGIOGRAPHYMarch 2022September 2022Allow620YesNo
17698568AUTOMATIC INJECTION DEVICE WITH A TOP RELEASE MECHANISMMarch 2022April 2024Allow2510NoNo
17697554MODULAR WEARABLE MEDICAMENT DELIVERY DEVICE AND METHOD OF USE THEREOFMarch 2022February 2024Allow2310NoNo
17696198INTEGRATED DELIVERY DEVICE FOR CONTINUOUS GLUCOSE SENSORMarch 2022June 2024Allow2720YesNo
17689882INFUSION PUMP SYSTEM WITH DISPOSABLE CARTRIDGE HAVING PRESSURE VENTING AND PRESSURE FEEDBACKMarch 2022June 2024Allow2720NoNo
17688578DRUG DELIVERY DEVICE, METHOD OF MANUFACTURE, AND METHOD OF USEMarch 2022June 2025Allow3930YesNo
17640139PEN NEEDLE WITH RETRACTABLE SHIELDMarch 2022January 2025Allow3400NoNo
17653174GLUCOSE LEVEL CONTROL SYSTEM WITH THERAPY CUSTOMIZATIONMarch 2022October 2022Allow710YesNo
17653121AMBULATORY MEDICAMENT PUMP WITH SAFE ACCESS CONTROLMarch 2022June 2022Allow300NoNo
17682880VARIABLE VOLUME INFUSION PORTFebruary 2022June 2024Abandon2811NoNo
17680975LOW-PROFILE STEERABLE CATHETERFebruary 2022June 2025Allow4010NoNo
17652456SYSTEMS AND METHODS FOR MONITORING DELIVERY OF MICRODOSES OF MEDICATIONFebruary 2022September 2022Allow710NoNo
17652453INITIALIZATION FOR SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATIONFebruary 2022August 2022Allow610NoNo
17631662Universal Cap With Pressure SealJanuary 2022February 2025Allow3700NoNo
17647325Robotically Augmented Catheter Manipulation HandleJanuary 2022November 2023Allow2210NoNo
17556761INTEGRATED DELIVERY DEVICE FOR CONTINUOUS GLUCOSE SENSORDecember 2021August 2024Allow3230YesNo
17554417Safety needle deviceDecember 2021July 2024Allow3110NoNo
17553671OCULAR DELIVERY SYSTEMS AND METHODSDecember 2021May 2022Allow510NoNo
17423943ERGONOMIC STEERING HANDLEDecember 2021December 2022Allow1621NoNo
17617507CATHETER INSERT DEVICESDecember 2021May 2025Allow4120NoNo
17538595Double-Lumen Percutaneous Femoral Cannula for Extracorporeal Membrane OxygenationNovember 2021January 2023Abandon1320YesNo
17454600REMOTELY ACTIVATED CANNULA INSERTIONNovember 2021September 2024Allow3410YesNo
17519665DEVICES FOR STEERING CATHETERSNovember 2021September 2023Allow2210NoNo
17518308Medical SyringeNovember 2021March 2025Allow4010NoNo
17509595PUMP CALIBRATION DURING BAG FILLINGOctober 2021August 2024Abandon3440YesNo
17450524ELECTRICALLY ENHANCED RETRIEVAL OF MATERIAL FROM VESSEL LUMENSOctober 2021January 2024Allow2720YesNo
17450236ELECTRICALLY ENHANCED RETRIEVAL OF MATERIAL FROM VESSEL LUMENSOctober 2021October 2023Allow2410NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BOUCHELLE, LAURA A.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
4
(80.0%)
Examiner Reversed
1
(20.0%)
Reversal Percentile
32.7%
Lower than average

What This Means

With a 20.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
25
Allowed After Appeal Filing
3
(12.0%)
Not Allowed After Appeal Filing
22
(88.0%)
Filing Benefit Percentile
12.5%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 12.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BOUCHELLE, LAURA A - Prosecution Strategy Guide

Executive Summary

Examiner BOUCHELLE, LAURA A works in Art Unit 3783 and has examined 558 patent applications in our dataset. With an allowance rate of 88.0%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.

Allowance Patterns

Examiner BOUCHELLE, LAURA A's allowance rate of 88.0% places them in the 64% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by BOUCHELLE, LAURA A receive 1.82 office actions before reaching final disposition. This places the examiner in the 56% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BOUCHELLE, LAURA A is 30 months. This places the examiner in the 44% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +4.2% benefit to allowance rate for applications examined by BOUCHELLE, LAURA A. This interview benefit is in the 27% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 29.4% of applications are subsequently allowed. This success rate is in the 47% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 51.6% of cases where such amendments are filed. This entry rate is in the 72% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 40.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 36% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 72.2% of appeals filed. This is in the 56% percentile among all examiners. Of these withdrawals, 61.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 37.9% are granted (fully or in part). This grant rate is in the 35% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 1.6% of allowed cases (in the 74% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 3.7% of allowed cases (in the 74% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

    Relevant MPEP Sections for Prosecution Strategy

    • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
    • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
    • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
    • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
    • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
    • MPEP § 1214.07: Reopening prosecution after appeal

    Important Disclaimer

    Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

    No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

    Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

    Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.